Nearly 120,000 young women have received a free HPV vaccine for the last two years and thus less risk of cervical cancer. Soon, the offer will be phased out.
The figures from the National Vaccination Register (SYSVAK) show that 53 percent of women who have had access to the two-year vaccination program have used it so far.
The program ensures that women born during the period 1991-1996 receive the vaccine that protects against HPV viruses, which can lead to cervical cancer. Since 2009 this vaccine has been given to all girls in the seventh grade, but those who went to school before this has not received it.
Senior and Public Health Minister Åse Michaelsen (Frp) is satisfied.
– HPV vaccine saves lives. Therefore, the government started the vaccination program in 2016, where young women born in 1991 or later have been offered a free HPV vaccine. Almost 120,000 women have used the offer so far. This is amazing, she says.
The state council recommends that all of the target groups begin the vaccination by the end of December. It is the last chance to take the first dose before the system is settled.
Dosage two and three must be taken no later than 1 July 2019.
– You must take all three doses for the best possible protection. We receive some questions from women if they need to be vaccinated again if there has been longer time than planned between the doses. They do not need it. It's fine that it took longer than planned, project manager Anita Daae said to the vaccination program for young women.
– Formidable effort
In addition to the figures for the whole country, the National Institute of Public Health also presents figures for the proportion of vaccinated women in different counties, municipalities and districts on Wednesday
"The municipal health service has done a formidable effort and has deposited 300,000 doses of HPV vaccines when the vaccination offer was launched two years ago. The highest proportion of vaccinated women is found in Trøndelag, closely followed by Sogn og Fjordane and Hordaland, victory Daae.
The lowest proportion of vaccinees is found in Østfold, Buskerud and Akershus.
Vaccine reduces the risk of developing severe cervical cavity by 90 percent in women who were not infected with HPV at the time of vaccination.